Harbour Investments »

Protalix Biotherapeutics shares owned by Harbour Investments

Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by Harbour Investments from 13F filings

Historical chart of Harbour Investments investment in Protalix Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protalix Biotherapeutics held by Harbour Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protalix Biotherapeutics by Harbour Investments

Quarter filed Position value Share count Share price at filing
2026-03-31 $13k 6.0k 2.17
2021-09-30 $4.0k 3.0k 1.33

More positions owned by Harbour Investments

Vanguard S&p 500 Etf Etf (VOO)
Invesco Qqq Trust Series I Etf (QQQ)
First Trust Smid Cap Rising Dividend Achievers Etf Etf (SDVY)
Apple Stock (AAPL)
First Trust Smith Unconstrained Bond Etf Etf (UCON)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Ft Vest Laddered Buffer Etf Etf (BUFR)
Ishares Core S&p Mid-cap Etf Etf (IJH)
Ishares Core S&p 500 Etf Etf (IVV)
Capital Group Core Plus Income Etf Etf (CGCP)
State Street Spdr S&p 500 Etf Etf (SPY)
First Trust Rising Dividend Achievers Etf Etf (RDVY)
Ishares S&p 500 Growth Etf Etf (IVW)
Ishares S&p 500 Value Etf Etf (IVE)
Schwab Us Dividend Equity Etf Etf (SCHD)

View all positions for Harbour Investments

Top funds holding Protalix Biotherapeutics

BlackRock
MAK Capital One
Renaissance Technologies
Northern Trust
Geode Capital Management
State Street Corporation
Stratos Wealth Partners
Vanguard Group
Vanguard Portfolio Management
Prospera Financial Services
Opaleye Management
Morgan Stanley
Dimensional Fund Advisors
UBS Group
Goldman Sachs Group

View all funds holding Protalix Biotherapeutics